{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=fluticasone%2Fsalmeterol", "query": { "intervention": "fluticasone/salmeterol" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 110, "total_pages": 11, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=fluticasone%2Fsalmeterol&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-13T20:35:07.776Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02573233", "title": "Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Dupilumab SAR231893/REGN668", "type": "DRUG" }, { "name": "fluticasone propionate and salmeterol", "type": "DRUG" }, { "name": "budesonide and formoterol", "type": "DRUG" }, { "name": "mometasone furoate and formoterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 42, "start_date": "2016-01-27", "completion_date": "2018-01-03", "has_results": true, "last_update_posted_date": "2022-04-04", "last_synced_at": "2026-09-13T20:35:07.776Z", "location_count": 6, "location_summary": "Tucson, Arizona • Denver, Colorado • Boston, Massachusetts + 3 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Denver", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02573233" }, { "nct_id": "NCT00927758", "title": "Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate/salmeterol (Flu/Sal) : 100mcg/50mcg, 250mcg/50mcg,500mcg/50 mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sandoz", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 105, "start_date": "2009-06", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2017-03-29", "last_synced_at": "2026-09-13T20:35:07.776Z", "location_count": 3, "location_summary": "Gainesville, Florida • Iowa City, Iowa • Madison, Wisconsin", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT00927758" }, { "nct_id": "NCT01879410", "title": "A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "UMEC/VI Inhalation Powder 62.5/25 mcg via NDPI", "type": "DRUG" }, { "name": "FSC Inhalation Powder 250/50 mcg via ACCUHALER/DISKUS", "type": "DRUG" }, { "name": "Placebo DISKUS", "type": "DRUG" }, { "name": "Placebo NDPI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 700, "start_date": "2013-06-13", "completion_date": "2014-01-09", "has_results": true, "last_update_posted_date": "2017-11-08", "last_synced_at": "2026-09-13T20:35:07.776Z", "location_count": 15, "location_summary": "Tucson, Arizona • Newport Beach, California • Riverside, California + 12 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Coeur d'Alene", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT01879410" }, { "nct_id": "NCT02554786", "title": "A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Indacaterol acetate/Mometasone furoate", "type": "DRUG" }, { "name": "Mometasone furoate", "type": "DRUG" }, { "name": "Salmeterol xinafoate/fluticasone propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 2216, "start_date": "2015-12-29", "completion_date": "2019-06-28", "has_results": true, "last_update_posted_date": "2020-03-05", "last_synced_at": "2026-09-13T20:35:07.776Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Los Angeles, California • Orange, California + 26 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02554786" }, { "nct_id": "NCT02260492", "title": "Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "OT329 (combination of fluticasone propionate and salmeterol xinafoate)", "type": "DRUG" }, { "name": "Advair Diskus (combination of fluticasone propionate and salmeterol xinafoate)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Oriel Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 879, "start_date": "2014-09", "completion_date": "2015-07", "has_results": true, "last_update_posted_date": "2017-06-15", "last_synced_at": "2026-09-13T20:35:07.776Z", "location_count": 47, "location_summary": "Goodyear, Arizona • Tempe, Arizona • Anaheim, California + 40 more", "locations": [ { "city": "Goodyear", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02260492" }, { "nct_id": "NCT02680561", "title": "A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Propionate MDPI", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol MDPI", "type": "DRUG" }, { "name": "Fluticasone propionate/salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 20, "start_date": "2016-04", "completion_date": "2016-08", "has_results": false, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-13T20:35:07.776Z", "location_count": 3, "location_summary": "Huntington Beach, California • Raleigh, North Carolina • San Antonio, Texas", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02680561" }, { "nct_id": "NCT02024204", "title": "Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lung Diseases", "Medication Compliance" ], "interventions": [ { "name": "Fluticasone propionate 230mcg for 3 Months", "type": "DRUG" }, { "name": "Current Treatment or no treatment", "type": "DRUG" }, { "name": "Salmeterol 21mcg for 3 Months", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 60, "start_date": "2014-04-09", "completion_date": "2017-05-17", "has_results": true, "last_update_posted_date": "2021-02-02", "last_synced_at": "2026-09-13T20:35:07.776Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02024204" }, { "nct_id": "NCT02649478", "title": "Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone / Salmeterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Advair Diskus 100/50", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roxane Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1430, "start_date": "2014-08", "completion_date": "2015-11", "has_results": false, "last_update_posted_date": "2018-01-23", "last_synced_at": "2026-09-13T20:35:07.776Z", "location_count": 100, "location_summary": "Glendale, Arizona • Phoenix, Arizona • Surprise, Arizona + 75 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Surprise", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02649478" }, { "nct_id": "NCT00400608", "title": "A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "ADVAIR HFA", "type": "DRUG" }, { "name": "ADVAIR DISKUS", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 28, "start_date": "2006-10", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-09-13T20:35:07.776Z", "location_count": 3, "location_summary": "Huntington Beach, California • Long Beach, California • Medford, Oregon", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Medford", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00400608" }, { "nct_id": "NCT01192178", "title": "Fall Epidemic Viral Pediatric Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FLOVENT™ DISKUS™ 100 mcg BID", "type": "DRUG" }, { "name": "ADVAIR™ DISKUS™ 100/50 mcg BID", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 339, "start_date": "2010-08", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2017-01-18", "last_synced_at": "2026-09-13T20:35:07.776Z", "location_count": 38, "location_summary": "Tucson, Arizona • Bakersfield, California • Fresno, California + 33 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Granada Hills", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01192178" } ] }